The FLASSH study: protocol for a randomised controlled trial evaluating falls prevention after stroke and two sub-studiesReportar como inadecuado

The FLASSH study: protocol for a randomised controlled trial evaluating falls prevention after stroke and two sub-studies - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Neurology

, 9:14

First Online: 31 March 2009Received: 09 March 2009Accepted: 31 March 2009


BackgroundFalls are common in stroke survivors returning home after rehabilitation, however there is currently a lack of evidence about preventing falls in this population. This paper describes the study protocol for the FLASSH FaLls prevention After Stroke Survivors return Home project.

Methods and designThis randomised controlled trial aims to evaluate the effectiveness of a multi-factorial falls prevention program for stroke survivors who are at high risk of falling when they return home after rehabilitation. Intervention will consist of a home exercise program as well as individualised falls prevention and injury minimisation strategies based on identified risk factors for falls. Additionally, two sub-studies will be implemented in order to explore other key areas related to falls in this population. The first of these is a longitudinal study evaluating the relationship between fear of falling, falls and function over twelve months, and the second evaluates residual impairment in gait stability and obstacle crossing twelve months after discharge from rehabilitation.

DiscussionThe results of the FLASSH project will inform falls prevention practice for stroke survivors. If the falls prevention program is shown to be effective, low cost strategies to prevent falls can be implemented for those at risk around the time of discharge from rehabilitation, thus improving safety and quality of life for stroke survivors. The two sub-studies will contribute to the overall understanding and management of falls risk in stroke survivors.

Trial registrationThis trial is registered with the Australian and New Zealand Clinical Trials Registry ACTRN012607000398404.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2377-9-14 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Frances A Batchelor - Keith D Hill - Shylie F Mackintosh - Catherine M Said - Craig H Whitehead


Documentos relacionados